| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1365-2141.1987.TB02261.X |
| P698 | PubMed publication ID | 3103670 |
| P2093 | author name string | V Bonnevie-Nielsen | |
| M Jørgensen | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | plasminogen | Q107129060 |
| thrombosis | Q261327 | ||
| P304 | page(s) | 175-180 | |
| P577 | publication date | 1987-02-01 | |
| P1433 | published in | British Journal of Haematology | Q4970200 |
| P1476 | title | Increased concentration of the fast-acting plasminogen activator inhibitor in plasma associated with familial venous thrombosis | |
| P478 | volume | 65 |
| Q50981804 | A novel G/A and the 4G/5G polymorphism within the promoter of the plasminogen activator inhibitor-1 gene in patients with deep vein thrombosis. |
| Q40868635 | Abnormalities of hemostasis in ischemic stroke. |
| Q34570102 | An embolus in the right atrium caught in the Chiari network and resistant to thrombolysis |
| Q60691560 | An embolus in the right atrium caught in the Chiari network and resistant to thrombolysis |
| Q54420587 | Elevated levels of plasminogen-activator inhibitor type 1 in atherosclerotic aorta. |
| Q73025879 | Elevations of tissue-type plasminogen activator and differential expression of urokinase-type plasminogen activator in diseased aorta |
| Q42494570 | Features of endothelial dysfunction in early diabetic nephropathy |
| Q40582633 | Fibrinolysis and thrombosis |
| Q71105567 | Fibrinolytic abnormalities in two different cutaneous manifestations of venous disease |
| Q67854052 | Gemfibrozil predictably lowers triglycerides but does not significantly change plasminogen activator inhibitor activity in hypertriglyceridemic patients with a history of thrombosis |
| Q36233246 | Hypercoagulability in Vascular Surgery Patients |
| Q44087714 | PAI-1 in human hypertension: relation to hypertensive groups |
| Q71718204 | Pathophysiology of fibrinolysis |
| Q34372572 | Plasminogen activator inhibitor type 1 gene is located at region q21.3-q22 of chromosome 7 and genetically linked with cystic fibrosis |
| Q71778269 | Plasminogen activator levels are influenced by location and varicosity in greater saphenous vein |
| Q67854048 | Poor fibrinolytic response to venous occlusion by different criteria in patients with deep vein thrombosis |
| Q69925034 | Protein C deficiency and portal thrombosis in liver transplantation in children |
| Q73484418 | Recurrent thromboembolism as a hallmark of Cushing’s syndrome |
| Q30419026 | The molecular genetics of familial venous thrombosis |
| Q37779898 | The role of fibrinolytic factors in ischaemia |
| Q38236911 | Tissue-type plasminogen activator. A review of its pharmacology and therapeutic use as a thrombolytic agent |
Search more.